Altshuler Shaham’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Altshuler Shaham’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-30,589	Closed	-$1.27M	–	636
2019 Q4	$1.27M	Hold	30,589	–	–	0.04%	72
2019 Q3	$453K	Hold	30,589	–	–	0.02%	91
2019 Q2	$1.07M	Sell	30,589 -9,621	-24%	-$522K	0.05%	77
2019 Q1	$2.26M	Buy	40,210 +10,534	+35%	+$570K	0.1%	41
2018 Q4	$1.43M	Sell	29,676 -39	-0.1%	-$2.14K	0.06%	70
2018 Q3	$2.16M	Hold	29,715	–	–	0.11%	51
2018 Q2	$2.45M	Buy	29,715 +3,060	+11%	+$296K	0.2%	53
2018 Q1	$2.8M	Sell	26,655 -12	-0%	-$1.43K	0.37%	27
2017 Q4	$3.42M	Buy	+26,667	New	+$3.28M	0.48%	17

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FMBTD

First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Altshuler Shaham's VBIV Position: Q1 2020 in Review

Altshuler Shaham sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2020, closing a stake of 30,589 shares — an estimated $1.27M sold.

Altshuler Shaham first reported a position in VBIV in Q4 2017 and held it in 9 quarters. The position peaked at $3.42M in Q4 2017. 71 funds tracked by Wall St. Rank hold VBIV as of Q1 2020.

Altshuler Shaham reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2020 after selling out during the quarter.
Altshuler Shaham sold 30,589 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2020, an estimated $1.27M.
Altshuler Shaham first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2017 and held it in 9 quarters.
Altshuler Shaham's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $3.42M in Q4 2017.
71 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2020.

Based on Altshuler Shaham's 13F filing for Q1 2020, filed 12 May 2020.